SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells

Overview of attention for article published in Journal of Hematology & Oncology, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 7,634 followers.

Congrats to Siret for her publication on multifunctional antibodies targeting AML #Immunotherapy

RT @hopfnerlab: Towards promising therapeutic interventions to treat Acute Myeloid Leukaemia (AML): collaborating with the @subklewe group,…

🩸 SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhanced the clearance of acute myeloid #leukemia-initiating cells, reports Drs. Karl-Peter Hopfner and Nadja Fenn at @LMU_Muenchen. #OpenAccess 🔓 https://t.co/qWqRqFtpiL

RT @hopfnerlab: Towards promising therapeutic interventions to treat Acute Myeloid Leukaemia (AML): collaborating with the @subklewe group,…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.